You searched for "legal"
Lawrence Werth (19 October 1956 – 19 August 2014)
In August the audiology community was saddened to learn that Lawrence Werth (57), Chairman of PC Werth Ltd, London had passed away after a brave battle with skin cancer. A prolific contributor to this magazine over the years, he is...
Should we be doing earlier MRIs in sudden sensorineural hearing loss?
There is recognised variation between ENT departments in exact imaging protocols for the workup of idiopathic sudden sensorineural hearing loss (ISSNHL) but a routine MRI to exclude retrocochlear pathology is standard, usually following immediate treatment with oral +/- intratympanic steroids....
Is there a role for hyperbaric treatment in sudden hearing loss?
Sudden sensorineural hearing loss is a common presentation to ENT departments with a significant difference in management both at a local and regional level. The authors seek to clarify the role of hyperbaric oxygen therapy in combination with oral and...
Local dexamethasone infiltration in tonsillectomy
Intravenous dexamethasone is routinely given during tonsillectomy for its effects on postoperative pain and nausea. This Chinese randomised study divided 240 children undergoing tonsillectomy into three groups, receiving either no steroid, intravenous dexamethasone, or the same amount of dexamethasone infiltrated...From ‘patients’ to ‘participants’: a career in audiological research
Melanie Lough is a clinical audiologist-turned-research audiologist and, in this article, we hear about how she applies her transferable skills gained in audiology to her current role and future aspirations. Career background My route into audiology was unconventional to say...Prof Quraishi OBE awarded Fellowship ad hominem FRCSEd
At a presentation ceremony on Friday 3 September, President of the Royal College of Surgeons of Edinburgh (FRCSEd), Prof Michael Griffin OBE, welcomed the members of the Council, fresh diplomates, their families and other guests. This was the first conferring...COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...
The ACS-NSQIP study – predictive risk factors and outcomes in primary malignant parotid tumour surgery
Malignant parotid gland tumours occupy a good proportion of the ENT surgeon’s operative caseload. Large standardised datasets for malignant parotid tumour surgery are limited. This international multi-institutional study is based on the pooled American College of Surgeons National Surgical Quality...CEORL-HNS observership travel grants
The Confederation of European ORL-HNS has announced a set of grants and scholarships for 2024.Sylvester O’Halloran Perioperative Symposium 2025
Dr Nyamateja Kaare - SHOThe 20th anniversary meeting of the Head & Neck section of the annual Sylvester O Halloran Peri-operative Symposium was held on 1 March 2025 at the University of Limerick Medical School.An attending 'Brains Trust' of John...The delivery of ENT services in Mongolia: what are its obstacles?
Globally, the burden of ENT disease is great. Disabling hearing loss (DHL) for example, is reported to affect half a billion people worldwide. The majority of afflicted individuals live in lower and middle-income countries (LMIC) [1]. This article, a collaboration...
